期刊文献+

乳腺癌超声造影定性及定量分析与p53表达的相关性研究 被引量:8

Qualitative and quantitative analysis and the relevance between contrast enhanced sonography of breast cancer and the expression of p53
暂未订购
导出
摘要 目的:探讨乳腺癌超声造影定性及定量特征与癌基因p53表达的相关性。方法:回顾性分析37例经手术及病理确诊的乳腺癌患者术前超声造影特征,术后对肿瘤标本用免疫组织学方法测定p53蛋白表达情况,并分析它与超声造影定性及定量特征之间的关系。结果:①该组乳腺癌肿块p53阳性表达率为43.2%(16/37)。②该组乳腺癌肿块的增强模式均以快速增强、高增强为主,与p53表达无关(P>0.05)。③p53阳性表达的乳腺癌肿块出现灌注缺损、穿支血管的几率增加,两者间有相关性(P<0.05)。④乳腺癌肿块超声造影时间-强度曲线定量分析表明,p53阳性表达的乳腺癌肿块峰值强度及曲线下面积增大,造影剂平均通过时间延长,与p53阴性表达的乳腺癌肿块之间均有显著性差异(P<0.05)。结论:乳腺癌超声造影定性及定量指标与p53阳性表达之间存在一定的相关性,时间-强度曲线定量分析较定性分析更能精确的评价乳腺癌肿块的内部血供情况,从而为临床选择正确的治疗方案提供参考。 Objective: To analyze relationship between contrast-enhanced ultrasound qualitative and quantitative features and expression of p53 in breast cancer. Methods: The contrast-enhanced ultrasound appearances of 37 breast carcinomas confirmed by pathology were analyzed. Immunohistochemieal method was used to test the expression of p53 in all the breast carcinomas, to analyze the relationship between it and the contrast-enhanced ultrasound appearances. Results: (1)The expres- sion rate of p53 were 43.2%(16/37). (2)The main enhanced pattern of breast carcinomas was fast and markedly enhanced, which was not related to the expression of p53 (P〉0.05). (3)The rate of perfusion defect or perforative vessels increased in breast carcinomas with p53 positive expression (P〈0.05). (4)The qualitative and quantitative analysis from the intensity-time curve of contrast-enhanced ultrasound in breast cancer showed, the peak intensity and the area under the curve were bigger in breast carcinomas with p53 positive expression compared to the breast carcinomas with p53 negative expression (P〈0.05). Conclusion: Qualitative and quantitative features of contrast-enhanced uhrasound were related to the expression of p53 in breast cancer in some extent. Quantitative analysis from intensity-time curve can give more accurate information about the blood supply of breast carcinoma, which will be helpful for selecting correct therapy method.
出处 《中国临床医学影像杂志》 CAS 2012年第7期465-467,487,共4页 Journal of China Clinic Medical Imaging
基金 广东省科技厅计划项目(No.2010B080702007)
关键词 乳腺肿瘤 基因 p53 超声检查 多普勒 彩色 Breast neoplasms Genes, p53 Uhrasonography, Doppler, color
  • 相关文献

参考文献15

  • 1Linjawi A, Kontogiannea M, Halwani F, et al. Prognostic signifi- cance of p53, bcl-2, and Bax expression in early breast cancer [J]. J Am Coil Surg, 2004, 198(1): 83-90.
  • 2黄宝俊,徐惠绵,李凯,王怀宇,张昊,田大彤.联合检测多基因在乳腺癌组织中的表达及其临床意义[J].中国普通外科杂志,2005,14(4):247-252. 被引量:11
  • 3Foster FS, Burns PN, Simpson DH, et al. Ultrasound for the vi- sualization and quantification of tumor microcirculation[J]. Cancer Metastasis Rev, 2000, 19(1-2): 131-138.
  • 4Zdemir A, Kilic K, Ozdemir H, et al. Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diag- nosis after mammography and gray scale sonography [J]. J Ultra- sound Med, 2004, 23(2): 183-195.
  • 5Jung EM, Jungius KP, Rupp N, et al. Contrast enhanced har- monic ultrasound for differentiating breast tumors-first resuhs. Clin Hemoheol Microcirc, 2005, 33(2): 109-120.
  • 6Schroeder RJ, Bostanjoglo M, Rademaker J, et al. Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions [J]. Eur Radiol, 2003, 13(1): 68-79.
  • 7Clegg HV, Itahana K, Zhang Y. Unlocking the Mdm2-p53 loop: ubiquitin is the key[J]. Cell Cycle, 2008, 7(3): 287-292.
  • 8Gautam A, Densmore CL, Mehon S, et al. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis[J]. Cancer Gene Ther, 2002, 9(1): 28- 36.
  • 9王禹,张颖超,杨威,关文曾.乳腺癌和良性乳腺疾病患者血清中VEGF的变化[J].吉林大学学报(医学版),2005,31(1):133-135. 被引量:8
  • 10Guidi AJ, Schnitt SJ, Fischer L, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angio- genesis in patients with ductal carcinoma in situ of the breast [J]. Cancer, 1997, 80(10): 1945-1953.

二级参考文献39

  • 1孟刚,张洪福,饶慧蓉,龚西.乳腺癌组织内微血管分布的定量研究[J].临床与实验病理学杂志,1995,11(1):17-19. 被引量:15
  • 2罗慧,罗奕伦,姜燕,冯晓凤,焦阳,彭启慧,彭树松.超声造影增强强度在乳腺肿块诊断中的价值[J].中国超声医学杂志,2007,23(2):107-110. 被引量:33
  • 3Balleyguier C, Opolon P, Mathieu M C, et al. New potential and applications of contrast-enhanced ultrasound of the breast:Own investigations and review of the literature[J]. Eur J Radiol, 2009, 69(1): 14-23.
  • 4Mie Lee Y, Kim SH, Kim H S, et al. Inhibition of hypoxiainduced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppressin of HIFlalpha activity [J]. BiochemBiophys Res Common, 2003, 300(1): 241-246.
  • 5Carmeliet D, Jain PK. Angiogenesis in cancer and other diseases [J]. Nature, 2000, 4 (7): 249.
  • 6Nicosia RF. What is the role of vascular endothelial growth factor-related molecules in angiogenesis [J]. Am J Path,1998, 153 (1): 11-16.
  • 7Heer K, Kumar H, Veikkola T, et al. Serum vascular endothelial growth factor in breast cancer [J]. Clin Cancer Res, 2001, 125 (7): 3491-3494.
  • 8Skobe M, Hawighorsit T, Jackson DG, et al. Induction of tumor lymph angiogenesis by VEGF-C promotes breast cancer metastasis [J]. Nat Med, 2001, 7 (2): 192-198.
  • 9Petit T, Borel C, Ghnassia JP, et al. Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting [ J ]. Clin Cancer Res, 2001 , 7(6) :1577 - 1581.
  • 10Sjostrom J, Collan J, yon Boguslawski K, et al. C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer [ J ].Eur J Cancer, 2002, 38 (4) :535 - 542.

共引文献30

同被引文献112

引证文献8

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部